|
English
|
正體中文
|
简体中文
|
2817371
|
|
???header.visitor??? :
27753052
???header.onlineuser??? :
187
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"conti i"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2021-01-12T12:49:04Z |
Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma
|
Cronier D.M.; Nguyen T.S.; Conti I.; Kaiser C.J.; Wooldridge J.E.; Tai D.F.; Kuliczkowski K.; Beksac M.; Raje N.S.; Moreau P.; Terpos E.; Benboubker L.; Grz??ko N.; Holstein S.A.; Oriol A.; SHANG-YI HUANG; Palumbo A. |
| 國立成功大學 |
2019 |
Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design
|
Moehler, Moehler M.;Ryu, M.-H.;Dvorkin, M.;Lee, K.-W.;Coşkun, H.Ş.;Wong, R.;Chung, H.C.;Poltoratsky, A.;Tsuji, A.;Yen, C.J.;Muntean, A.S.;Le, Sourd S.;Vaccaro, G.M.;Overton, L.;Boku, N.;Wainberg, Z.A.;Patel, M.;Sharma, M.;Xiong, H.;Conti, I.;Taieb, J.;Bang, Y.-J. |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
